← Back to All Filings

Health In Tech (HIT) Director Awarded ~$20k in Restricted Stock

Low SignificanceOctober 10, 2025 at 5:34:05 PM EDT

Health In Tech, Inc.

$HIT4CIK: 0002019505

Subscribe to track HIT

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Health In Tech (HIT) Director Awarded ~$20k in Restricted Stock

Company: Health In Tech, Inc. (HIT) Form: 4 | Filed: 2025-10-10 Significance: Low

Insider: Hayes Timothy Title: null | Relationship: Director

Transaction: • Type: Stock Award • Shares: 5,730 • Price: $3.49 • Value: $19,998 • Owned After: 106,045

Key Insight: A Director received a routine grant of restricted stock as part of their compensation package. This is not an open-market purchase and has low trading significance.

Market Context: The filing also disclosed a forfeiture of 28,159 previously granted shares, resulting in a net decrease in the director's holdings from the day's reported events.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Health In Tech, Inc. (HIT)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director of Health In Tech, Inc. was awarded approximately $20,000 in restricted stock as part of a standard compensation plan. This is a routine event and not an open-market transaction, indicating a neutral signal to the market.
  • Market Impact: The transaction is expected to have a neutral market impact due to its nature as a compensation grant and its relatively small value.

Company Information

FieldValue
CompanyHealth In Tech, Inc.
Ticker SymbolHIT
CIK0002019505
IndustryInsurance Agents Brokers & Services

Insider Information

FieldValue
NameHayes Timothy
CIK0002020283
Title/Positionnull
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2025-10-08
Transaction CodeA (Award)
Security TypeClass A Common Stock
Shares Involved5,730
Price Per Share$3.49
Total Value$19,997.70
Shares Owned After106,045
Ownership TypeDirect

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This transaction is a stock award (Code 'A'), which is a form of non-cash compensation. It aligns the director's interests with shareholders but does not represent a conviction buy with personal capital. Such grants are common and typically do not influence stock price significantly.

Volume & Sentiment

  • Expected Volume Impact: Negligible. Compensation-related grants are not open-market trades and do not affect trading volume.
  • Sentiment Indicator: Neutral. While insider ownership is a positive, a small, routine grant does not typically generate strong bullish or bearish sentiment.

Investment Insights

Positive Market Indicators

  • Equity-based compensation helps align the interests of the board with those of the shareholders.

Risk Factors

  • The filing also reported a separate transaction where the insider forfeited 28,159 shares on October 3, 2025. The net effect of the two reported transactions is a decrease in the insider's holdings.
  • The value of the award is minimal and does not signal a major new commitment from the insider.

Key Takeaways

  1. Routine Compensation: The award of 5,730 shares is a standard grant under the company's equity incentive plan.
  2. Not an Open-Market Trade: This was not a purchase of shares on the open market, which would have been a stronger bullish signal.
  3. Context is Key: The award should be viewed in the context of the simultaneous forfeiture of a larger number of shares, which was tied to a specific event (annual stockholders meeting).

Contextual Analysis

Timing Significance

The transactions are dated shortly after the company's annual stockholders meeting, suggesting they are part of a regular, scheduled compensation and vesting cycle.

Transaction Context

  • Footnote F1: Explains the disposal of 28,159 shares was a forfeiture of restricted stock tied to the annual meeting on October 3, 2025.
  • Footnote F2: Clarifies the acquisition of 5,730 shares is a new grant of restricted stock that will vest quarterly, contingent on the director's continued service.
  • Footnote F3: Confirms the final ownership of 106,045 shares includes the newly granted 5,730 restricted shares.

Company Context

The filing does not provide additional context on recent company performance or news. The transactions appear to be administrative and related to the company's established equity compensation program.

Risk Assessment

Risk Level: Low

Risk Factors

  • This specific filing does not introduce new risks. It reflects standard corporate governance procedures.

Market Considerations

  • Investors should distinguish between insider open-market buys/sells and compensation-related grants/awards.
  • The net decrease in shares held by the insider from these two specific events (award vs. forfeiture) is a point of information but likely not a bearish signal given the nature of the forfeiture.

IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.

Analysis generated on 2025-10-10 | Data source: SEC EDGAR

Topics:#SECFiling#InsiderTrading#Form4#HIT#HITStock#StockAward#CorporateGovernance#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.